Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis.
Johnson SD, Olwenyi OA, Bhyravbhatla N, Thurman M, Pandey K, Klug EA, Johnston M, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Mohan M, Singh K, Byrareddy SN. Johnson SD, et al. Among authors: singh k. World J Gastroenterol. 2021 Aug 7;27(29):4763-4783. doi: 10.3748/wjg.v27.i29.4763. World J Gastroenterol. 2021. PMID: 34447225 Free PMC article. Review.
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.
Neogi U, Hill KJ, Ambikan AT, Heng X, Quinn TP, Byrareddy SN, Sönnerborg A, Sarafianos SG, Singh K. Neogi U, et al. Among authors: singh k. Pathogens. 2020 Apr 26;9(5):320. doi: 10.3390/pathogens9050320. Pathogens. 2020. PMID: 32357471 Free PMC article.
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
Appelberg S, Gupta S, Svensson Akusjärvi S, Ambikan AT, Mikaeloff F, Saccon E, Végvári Á, Benfeitas R, Sperk M, Ståhlberg M, Krishnan S, Singh K, Penninger JM, Mirazimi A, Neogi U. Appelberg S, et al. Among authors: singh k. Emerg Microbes Infect. 2020 Dec;9(1):1748-1760. doi: 10.1080/22221751.2020.1799723. Emerg Microbes Infect. 2020. PMID: 32691695 Free PMC article.
Infectivity of SARS-CoV-2: there Is Something More than D614G?
Kannan SR, Spratt AN, Quinn TP, Heng X, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Kannan SR, et al. Among authors: singh k. J Neuroimmune Pharmacol. 2020 Dec;15(4):574-577. doi: 10.1007/s11481-020-09954-3. Epub 2020 Sep 15. J Neuroimmune Pharmacol. 2020. PMID: 32930936 Free PMC article. No abstract available.
Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants.
Spratt AN, Kannan SR, Woods LT, Weisman GA, Quinn TP, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Spratt AN, et al. Among authors: singh k. bioRxiv [Preprint]. 2021 Mar 24:2021.03.24.436850. doi: 10.1101/2021.03.24.436850. bioRxiv. 2021. PMID: 33791700 Free PMC article. Preprint.
Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors.
Acharya A, Pandey K, Thurman M, Klug E, Trivedi J, Lorson CL, Singh K, Byrareddy SN. Acharya A, et al. Among authors: singh k. bioRxiv [Preprint]. 2021 Apr 2:2021.04.02.438204. doi: 10.1101/2021.04.02.438204. bioRxiv. 2021. PMID: 33821265 Free PMC article. Updated. Preprint.
9,418 results